Minerva Neurosciences NERV
NASDAQ NERV
$2.50 -0.13 (-4.94%)
As of: Nov 10, 2026 · 1:47 PM EST

Minerva Neurosciences (NERV) FCF Margin (2014 - 2020)

Updated

Minerva Neurosciences' FCF Margin came in at -82.14% for FY2020.

Analysis

Minerva Neurosciences (NERV) FCF Margin (2014 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 33.69%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 25.03%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 41.97%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 30.51%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 38.60%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 35.25%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 57.81%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 28.96%
10 Minerva Neurosciences 121.62 Mn -126.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 -18.43%
Dec 31, 2014 -167,619,700.00%
API Access

Minerva Neurosciences FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=NERV&period=max&api_key=YOUR_API_KEY